Second generic clears Health Canada Gerstein's comments came as Health Canada confirmed on May 1, 2026, that it had authorized a second generic semaglutide injection, filed by Toronto-headquartered Apotex as a generic version of Ozempic [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html]
10.1002/bdra.20063 91 SperandeoM
I had invested my time everything into this procedure to ensure that it was going to work for me
Lotte Bjerre Knudsen (43:30): I think we've been around all the exciting biology of GLP-1, both in diabetes, obesity, cardiovascular, kidney, potential in Alzheimer's and addiction
Addressing Specific Hunger Patterns If a patient experiences intense head hunger or cravings that the GLP-1 is not fully suppressing, the stimulant effect of phentermine might be used to target those specific neurological triggers